| Mankind Pharma Ltd [26-Oct-26] |
Considered and approved the Scheme of Arrangement for amalgamation of Prolijune Lifesciences Private Limited (Transferor Company 1) and Pavi Buildwell Private Limited (Transferor Company 2), both being wholly owned subsidiaries of the Company, with and into Mankind Pharma Limited (Transferee Company Company) and their respective shareholders and creditors (Scheme 1 Scheme of Arrangement), pursuant to Sections 230 to 232 and other applicable provisions of the Companies Act, 2013, read with the rules made thereunder. The Appointed Date for the Scheme of Arrangement is as defined therein i.e. April 01, 2027.
|
| Mankind Pharma Ltd [26-Oct-26] |
Considered and approved the Scheme of Arrangement for amalgamation of Prolijune Lifesciences Private Limited (Transferor Company 1) and Pavi Buildwell Private Limited (Transferor Company 2), both being wholly owned subsidiaries of the Company, with and into Mankind Pharma Limited (Transferee Company Company and their respective shareholders and creditors Scheme 1 Scheme of Arrangement pursuant to Sections 230 to 232 and other applicable provisions of the Companies Act, 2013, read with the rules made thereunder. The Appointed Date for the Scheme of Arrangement is as defined therein i.e. April 01, 2027 |
| Mankind Pharma Ltd [26-Oct-26] |
Considered and took note of the Scheme of Arrangement for amalgamation of Upakarma Ayurveda Private Limited (Transferor Company UAPL) with and into Mankind Consumer Products Private Limited (Transferee Company MCPPL) (Scheme 2), as approved by the respective Boards of Directors of UAPL and MCPPL at their meetings held earlier today, as communicated by the said wholly owned subsidiaries to the Company today, i.e., October 26, 2026. MCPPL is a wholly owned subsidiary of the Company, while UAPL is a wholly owned subsidiary of MCPPL and accordingly, a step down wholly owned subsidiary of the Company. The proposed Scheme 2 is subject to receipt of requisite statutory, regulatory and other approvals, as may be applicable. |
| Heritage Foods Ltd [23-Oct-26] |
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform you that the Board of Directors of the Company, at its meeting held today, i.e., October 23, 2026, has approved the Scheme of Amalgamation under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013, read with the rules made thereunder, for the amalgamation of its wholly-owned subsidiary, Heritage Novandie Foods Limited (Transferor Company), with Heritage Foods Limited (Transferee Company or the Company). |
| Newgen Software Technologies Ltd [23-Oct-26] |
Enclosed Outcome of Board Meeting held on 23rd October 2026 |